Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

Author： Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.71, Iss.1, 2005-01, pp. : 61-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: A Hellenic Cooperative Oncology Group (HeCOG) phase II study

By Makatsoris Thomas   Papakostas Pavlos   Kalofonos Haralabos   Xanthakis Ioannis   Tsavdaridis Dimitrios   Aravantinos Gerasimos   Gogas Helen   Klouvas George   Kosmidis Paris   Pectasides Dimitrios   Fountzilas George  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 301-307

Humana Press, Inc

Access to resources Recommend Favorite

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study

By                                  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 216-224

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation

By Fountzilas George   Bobos Mattheos   Kalogera-Fountzila Anna   Xiros Nikolaos   Murray Samuel   Linardou Helena   Karayannopoulou Georgia   Koutras Angelos   Bafaloukos Dimitrios   Samantas Epaminondas   Christodoulou Christos   Economopoulos Theofanis   Kalogeras Konstantine   Kosmidis Paris  

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 784-793

Informa Healthcare

Access to resources Recommend Favorite

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

By Bamias A.   Dafni U.   Karadimou A.   Timotheadou E.   Aravantinos G.   Psyrri A.   Xanthakis I.   Tsiatas M.   Koutoulidis V.   Constantinidis C.   Hatzimouratidis C.   Samantas E.   Visvikis A.   Chrisophos M.   Stravodimos K.   Deliveliotis C.   Eleftheraki A.   Pectasides D.   Fountzilas G.   Dimopoulos M. A.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1011-1017

Oxford University Press

Access to resources Recommend Favorite